Tuesday, Dec 11, 2018
engineered enzymes for better healthcare

生物素酰胺酶缺乏症 (BIO) 是由于缺乏释放结合状态生物素的生物素酶所导致的。如果没有足够的游离生物素,其他几个关键的酶系统就无法正常发挥功能。新生儿的发病率大约为 1/60,000,该缺乏症可能导致发育迟缓、中风、湿疹、重度听力损失等,严重时可能导致死亡。 治疗方法很简单,只需每日补充一定剂量的生物素即可。

产品信息

 

amino-acid-disorders-product酶缺乏症紊乱

GAL           半乳糖血症

G6PD         葡萄糖-6-磷酸脱氢酶缺乏症

BIO           生物素酰胺酶缺乏症

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...